Vanguard Group Inc. lifted its position in Natera, Inc. (NASDAQ:NTRA) by 12.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,261,052 shares of the medical research company’s stock after buying an additional 253,344 shares during the quarter. Vanguard Group Inc. owned about 4.28% of Natera worth $24,555,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently modified their holdings of NTRA. American International Group Inc. lifted its stake in shares of Natera by 7.1% in the first quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock worth $142,000 after buying an additional 1,068 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in shares of Natera in the second quarter worth $151,000. Goldman Sachs Group Inc. lifted its stake in shares of Natera by 45.3% in the first quarter. Goldman Sachs Group Inc. now owns 17,386 shares of the medical research company’s stock worth $154,000 after buying an additional 5,417 shares during the last quarter. Wells Fargo & Company MN lifted its stake in shares of Natera by 2.8% in the second quarter. Wells Fargo & Company MN now owns 18,031 shares of the medical research company’s stock worth $195,000 after buying an additional 491 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its stake in shares of Natera by 5.6% in the first quarter. Alliancebernstein L.P. now owns 26,600 shares of the medical research company’s stock worth $236,000 after buying an additional 1,400 shares during the last quarter. Institutional investors and hedge funds own 60.54% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Vanguard Group Inc. Has $24.56 Million Stake in Natera, Inc. (NTRA)” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/vanguard-group-inc-has-24-56-million-stake-in-natera-inc-ntra/1699457.html.

In related news, insider Jonathan Sheena sold 120,000 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $12.54, for a total transaction of $1,504,800.00. Following the completion of the transaction, the insider now directly owns 533,208 shares in the company, valued at approximately $6,686,428.32. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 12.57% of the stock is owned by corporate insiders.

Natera, Inc. (NASDAQ:NTRA) opened at $9.19 on Monday. Natera, Inc. has a one year low of $7.35 and a one year high of $14.76. The company has a quick ratio of 1.75, a current ratio of 1.85 and a debt-to-equity ratio of 2.43.

Natera (NASDAQ:NTRA) last released its earnings results on Wednesday, November 8th. The medical research company reported ($0.51) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.47) by ($0.04). The company had revenue of $56.66 million for the quarter, compared to analyst estimates of $55.31 million. Natera had a negative net margin of 62.34% and a negative return on equity of 197.09%. Natera’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.50) earnings per share. equities research analysts expect that Natera, Inc. will post -2.12 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on NTRA shares. Zacks Investment Research cut shares of Natera from a “buy” rating to a “hold” rating in a research note on Thursday, October 26th. BidaskClub upgraded shares of Natera from a “sell” rating to a “hold” rating in a research note on Wednesday, August 23rd. ValuEngine upgraded shares of Natera from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 10th. Morgan Stanley cut their target price on shares of Natera from $18.00 to $13.00 and set an “overweight” rating for the company in a research note on Monday, August 7th. Finally, Robert W. Baird reiterated a “buy” rating on shares of Natera in a research note on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $15.25.

Natera Profile

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.